Back
Solid Biosciences Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
79
SLDB
Solid Biosciences
Last Price:
10.26
Seasonality Move:
5.81%
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
132.54
Seasonality Move:
14.17%
Buy
79
Solid Biosciences (SLDB)
is a Buy
Is Solid Biosciences a Buy, Sell or Hold?
- The current Solid Biosciences [SLDB] share price is $10.43. The Score for SLDB is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- SLDB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $136.11. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SLDB Stock Price Chart
What is Solid Biosciences's stock price today?
-
The Solid Biosciences share price today is $10.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLDB is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $136.11
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
SLDB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 53.28 | Buy |
| Chaikin Money Flow: | 102599 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.91 - 11.29) | Buy |
| Bollinger Bands (100): | (6.68 - 11.58) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.61 | Buy |
| Relative Strength Index (14 RSI): | 70.24 | Buy |
| Chaikin Money Flow: | -896291 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.2 - 130.96) | Buy |
| Bollinger Bands (100): | (107.36 - 132.38) | Buy |
SLDB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.62 | Buy |
| 20-day SMA: | 9.6 | Buy |
| 50-day SMA: | 10.97 | Sell |
| 200-day SMA: | 6.12 | Buy |
| 8-day EMA: | 9.82 | Buy |
| 20-day EMA: | 9.95 | Buy |
| 50-day EMA: | 10.1 | Buy |
| 200-day EMA: | 7.74 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.29 | Buy |
| 20-day SMA: | 124.75 | Buy |
| 50-day SMA: | 125.69 | Buy |
| 200-day SMA: | 112.46 | Buy |
| 8-day EMA: | 131.37 | Buy |
| 20-day EMA: | 127.6 | Buy |
| 50-day EMA: | 124.92 | Buy |
| 200-day EMA: | 117.07 | Buy |
Solid Biosciences Earnings Growth & SLDB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.22 per share, and a decrease next year of $0.65 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.85 per share, an increase next quarter of $1.52 per share, an increase this year of $5.62 per share, and an increase next year of $6.11 per share.
Solid Biosciences Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||